- Filed
- Feb 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jan 21, 2025 | 181.05M sh |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $3.64B |
| Long Term Debt | Q3 2025 · Mar 31, 2024 | $3.82B |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.72B |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $1.22B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $2.99B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $2.81B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $3.79B |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $4.39B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $9.78B |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $10.81B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $5.08B |
| Current Assets | Q3 2025 · Mar 31, 2024 | $5.14B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $13.03B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $13.87B |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 191.93M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 203.55M sh |
| Stock Repurchased | Q3 2025 · Dec 31, 2023 | $755M |
| Capex | Q3 2025 · Dec 31, 2023 | $144M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | $1.08B |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $0.81 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $1.43 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $0.82 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $1.45 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $294M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $949M |
| Net Income | Q3 2025 · Dec 31, 2023 | $156M |
| Net Income | Q3 2025 · Dec 31, 2023 | $291M |
| Operating Income restated | Q3 2025 · Dec 31, 2023 | $256M |
| Operating Income restated | Q3 2025 · Dec 31, 2023 | $725M |
| Revenue | Q3 2025 · Dec 31, 2023 | $3.4B |
| Revenue | Q3 2025 · Dec 31, 2023 | $10.28B |